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Background
Allosteric biosensors are based on engineered reporter
enzymes responsive to analyte binding through detectable
changes in the specific activity [1,2]. Since antibodies are
efficient allosteric effectors, such devices are especially
useful for the diagnosis of infectious diseases. In previous
studies, we have introduced an antigenic peptide from the
HIV structural protein gp41, spanning amino acids 579 to
613 of the Env precursor [3], into a permissive site of E.
coli beta-galactosidase, resulting in the chimeric protein
NF795gpC. In the presence of immune sera or anti-pep-
tide antibodies, the soluble enzyme is efficiently activated
in a fast and homogeneous immunoassay [3,4]. To further
develop biosensor devices in solid phases, with wider
applicability in field conditions, we have here explored
the allosteric properties of NF795gpC when immobilized
in an agarose substrate.
Results
The immobilization process was optimised by using a
commercial beta-galactosidase and different crosslinked
types of agarose, from which we finally considered 4BCL
as the optimum for the assay because it permitted the total
accommodation of the protein in the agarose porus. We
monitored the binding process through activity assays (at
pH 9.5) along time in supernatant and suspension, always
controlling the stability of the protein [5]. The decrease of
activity in the supernatant and not in the suspension indi-
cates the efficient joining of the soluble protein to the sup-
port.
After that, we checked the activation capacity of immobi-
lized NF795gpC upon the exposure to an anti-peptide
antibody. In figure 1 it is compared the allosteric activa-
tion of the immobilized NF795gpC beta-galactosidase
and its soluble version. Clearly, the protein maintains its
allosteric activation properties even in its immobilized
form, although with a differential, and slightly delayed
profile regarding the soluble form.
Conclusion
NF795gpC is responsive to the allosteric modification
mediated by anti-peptide antibodies even when immobi-
lized in an agarose support, proving that the conforma-
tional modifications induced by the adaptive binding and
supporting activation do not require the protein in solu-
tion. The different activation kinetics observed in soluble
and immobilized enzyme versions could be due to either
structural constraints to the active site conformational
modulation or to a differential accessibility of the anti-
genic peptide (the allosteric receptor) to activating anti-
bodies. The obtained results are promising regarding the
possible use of allosteric biosensors in solid-phase plat-
forms.
from The 4th Recombinant Protein Production Meeting: a comparative view on host physiology
Barcelona, Spain. 21–23 September 2006
Published: 10 October 2006
Microbial Cell Factories 2006, 5(Suppl 1):P43 doi:10.1186/1475-2859-5-S1-P43
<supplement> <title> <p>The 4th Recombinant Protein Production Meeting: a comparative view on host physiology</p> </title> <sponsor> <note>The organisers would like to thank Novozymes Delta Ltd who generously supported the meeting.</note> </sponsor> <note>Meeting abstracts – A single PDF containing all abstracts in this supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1475-2859-5-S1-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1475-2859-5-S1-info.pdf</url> </supplement>
© 2006 Ferraz et al; licensee BioMed Central Ltd. Page 1 of 2
(page number not for citation purposes)
Microbial Cell Factories 2006, 5(Suppl 1):P43Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright




This work has been funded by BIO2004-00700 from MEC, Spain and 
2005SGR-00956 (AGAUR). Rosa Maria Ferraz is recipient of a doctoral fel-
lowship from Departament d'Universitats, Recerca i Societat de la Informa-
ció de la Generalitat de Catalunya i del Fons Social Europeu.
References
1. Villaverde A: Allosteric enzymes as biosensors for molecular
diagnosis.  FEBS Lett 2003, 554:169-172.
2. Ferraz RM, Vera A, Arís A, Villaverde A: Insertional protein engi-
neering for analytical molecular sensing.  Microb cell Fact 2006,
5:15.
3. Ferrer-Miralles N, Feliu JX, Vandevuer S, Müller A, Cabrera-Crespo
J, Ortmans I, Hoffmann F, Cazorla D, Rinas U, Prévost M, Villaverde
A: Engineering regulable E. coli beta-galactosidases as bio-
sensors for anti-HIV antibody detection in human sera.  J Biol
Chem 2001, 276:40087-40095.
4. Ferraz RM, Arís A, Villaverde A: Profiling the allosteric response
of an engineered beta-galactosidase to its effector, anti-HIV
antibody.  Biochem Biophys Res Commun 2004, 314:854-860.
5. Álvaro G, Fernández-La Fuente R, Blanco RM, Guisán JM: Immobili-
zation-Stabilization of Penicillin G Acylase from Escherichia
coli .  Appl Biochem Biotechnol 1990, 26:181-195.
Coloured product of the ONPG hydrolysis formed by immobilized (A) and soluble (B) beta-galactosidase NF795gpC in pres-ence (❍) and in absence (●) of an anti-peptide antibodyFigure 1
Coloured product of the ONPG hydrolysis formed by immobilized (A) and soluble (B) beta-galactosidase NF795gpC in pres-
ence (❍) and in absence (●) of an anti-peptide antibody.
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